Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 411

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 411
---
 by WithumSmith+Brown PC, an independent registered public accounting firm, as set forth in their report (which contains an explanatory paragraph relating to the substantial doubt about the ability of Liminatus Pharma, LLC to continue as a going concern as described in Note 1 to the financial statements) thereon appearing elsewhere in this proxy statement/prospectus, and are included in reliance on such report given on the authority of such firm as an expert in accounting and auditing.

<div align='center'>226</div>

TABLE OF CONTENTS

### APPRAISAL RIGHTS
There are no appraisal rights available to our stockholders in connection with the Business Combination.

### DELIVERY OF DOCUMENTS TO STOCKHOLDERS
Pursuant to the rules of the SEC, we and servicers that we employ to deliver communications to our stockholders are permitted to deliver to two or more stockholders sharing the same address a single copy of the proxy statement/prospectus. Upon written or oral request, we will deliver a separate copy of the proxy statement/prospectus to any stockholder at a shared address to which a single copy of the proxy statement/ prospectus was delivered and who wishes to receive separate copies in the future. Stockholders receiving multiple copies of the proxy statement/prospectus may likewise request that we deliver single copies of the proxy statement/prospectus in the future. Stockholders may notify us of their requests by calling or writing us at our principal executive offices at +97143966949 and 3rd Floor Zephyr House, 122 Mary Street, George Town, PO Box 10085, Grand Cayman KY1-1001, Cayman Islands.

### TRANSFER AGENT AND REGISTRAR
The Transfer Agent for the securities of Iris and ParentCo is Continental Stock Transfer & Trust Company.

### SUBMISSION OF STOCKHOLDER PROPOSALS
The Iris Board is aware of no other matter that may be brought before the Special Meeting. Under Delaware law, only business that is specified in the notice of special meeting to stockholders may be transacted at the Special Meeting.

### STOCKHOLDER PROPOSALS
If the Business Combination is consummated and ParentCo holds a 2026 annual meeting of stockholders, it will provide notice of or otherwise publicly disclose the date on which the 2026 annual meeting will be held. If the 2026 annual meeting is held, stockholder proposals will be eligible for consideration by the directors for inclusion in the proxy statement for ParentCo’s 2026 annual general meeting in accordance